🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Nephritis

A Study of SHR-2173 in Participants With Primary IgA Nephropathy NCT07354932Phase 22 sites📍 Guangzhou📍 Shanghai Guangdong Hengrui Pharmaceutical Co., Ltd · Tests: SHR-2173 injection, SHR-2173 injection, SHR-2173 injection, Placebo A Study of JADE101 in Participants With Immunoglobulin A Nephropathy NCT07541287Phase 220 sites📍 Chula Vista📍 Arvada📍 Denver Jade Biosciences, Inc. · Tests: JADE101 Correlation of Microbiome and Metabonomics With IgA Nephropathy NCT05190848n/a5 sites📍 Guangzhou📍 Guangzhou📍 Guangzhou Guangdong Provincial People's Hospital The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study NCT05538208Phase 219 sites📍 San Francisco📍 Aurora📍 Atlanta Children's Hospital Medical Center, Cincinnati · Tests: Mycophenolate Mofetil, Mycophenolate Mofetil Genotype-Phenotype Correlations in Patients With Alport Syndrome NCT04947813n/a1 site📍 Shanghai Xinhua Hospital, Shanghai Jiao Tong University School of Me… A Phase 1 Study of CLYM116 in Normal Healthy Volunteers NCT07248865Phase 11 site📍 Brisbane Climb Bio, Inc. · Tests: CLYM116, Placebo A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. NCT07203404EARLY Phase 11 site📍 Shanghai Nanjing Bioheng Biotech Co., Ltd. · Tests: RD06-05 CART Cell Injection IgA Nephropathy Biomarkers Evaluation Study (INTEREST) NCT02954419n/a1 site📍 Guangzhou Sun Yat-sen University · Tests: No intervention A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) NCT06557265Phase 1, Phase 219 sites📍 Little Rock📍 Tustin📍 Gainesville Nkarta, Inc. · Tests: NKX019, Fludarabine, Cyclophosphamide A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS) NCT05583942NA2 sites📍 New Hyde Park📍 Philadelphia Northwell Health · Tests: trascutaneous auricular vagus nerve stimulation, Sham device Finerenone Therapy for Pediatric HSPN With Mild Proteinuria NCT07315191Phase 41 site📍 Beijing Capital Institute of Pediatrics, China · Tests: ACEI / ARB+finerenone, ACEI/ARB China Kidney Patient Trials Network NCT05036850n/a1 site📍 Beijing George (Beijing) Clinical Research Co. Ltd. Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) NCT06350110Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: CD19- BCMA CAR-T cells Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor NCT05508009Phase 1, Phase 21 site📍 Palo Alto Alice Bertaina · Tests: Cyclophosphamide 1200 mg/Kg, Fludarabine, Cyclophosphamide 100 mg/Kg, Total Body Irradiation, ATG Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone NCT07760480Phase 41 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Kidney Biopsy, Voclosporin (LUPKYNIS), Blood, feces and urine sample collection, LupusPRO questionnaire, Mycophenolate … The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis NCT02954939NA1 site📍 Hong Kong The University of Hong Kong · Tests: MMF-MMF, CTX-AZA NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis NCT06676631Phase 11 site📍 Guangzhou Guangdong Provincial People's Hospital · Tests: NK 010 or NK042, Rituximab The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA) NCT04858724n/a1 site📍 Shanghai Ruijin Hospital Study of BHV-1400 in IgA Nephropathy NCT07054684Phase 115 sites📍 Farmington📍 Miami Lakes📍 Miami Lakes Biohaven Therapeutics Ltd. · Tests: BHV-1400 Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport) NCT05927467n/a1 site📍 Paris Institut National de la Santé Et de la Recherche Médicale, … Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients NCT06631404n/a1 site📍 Sohag Sohag University · Tests: renal doppler The Validity of the Quick Renal MRI in Pediatric Kidney Disease NCT03959163NA1 site📍 Madison University of Wisconsin, Madison · Tests: Quick MRI Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy NCT05839314Phase 41 site📍 Beijing Chinese PLA General Hospital · Tests: Huaier granule, Renin-angiotensin-aldosterone system inhibitors (RASI), Ciclosporin soft capsules CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease NCT07305116Phase 11 site📍 Hangzhou The Children's Hospital of Zhejiang University School of Me… · Tests: UCAR T-cell Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps) NCT06821919n/a1 site📍 Nahariya Western Galilee Hospital-Nahariya Nephrotic Syndrome Study Network NCT01209000n/a44 sites📍 Los Angeles📍 Palo Alto📍 San Francisco University of Michigan · Tests: Kidney Biopsy Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. NCT05505500n/a1 site📍 Ann Arbor University of Michigan · Tests: Interview IgA Nephropathy Registration Initiative of High Quality (INSIGHT) NCT03001947n/a1 site📍 Guangzhou Sun Yat-sen University · Tests: No intervention A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US NCT06952426n/a1 site📍 Boston Novartis Pharmaceuticals · Tests: No intervention, Other treatment, Iptacopan, Atrasentan Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease NCT05650619n/a1 site📍 Ann Arbor University of Michigan · Tests: Biospecimen collection, Data collection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy